Share This Page
Drug Price Trends for VIRTUSSIN AC LIQUID
✉ Email this page to a colleague
VIRTUSSIN AC LIQUID Market Analysis and Financial Projection
Market Analysis and Price Projections for Virtussin AC Liquid
Overview of Virtussin AC
Virtussin AC is a combination medication that includes codeine phosphate, an antitussive (cough suppressant), and guaifenesin, an expectorant. These active ingredients work together to relieve coughs and congestion associated with common colds, allergies, and respiratory illnesses like bronchitis[1][4].
Market Presence and Popularity
Virtussin AC and its counterpart, Cheratussin AC, are widely prescribed cough suppressants. In 2020, Virtussin AC accounted for approximately 3 million prescriptions in the US, representing about 15% of all prescription cough syrups containing narcotics. Cheratussin AC had slightly higher numbers, with around 4 million prescriptions, accounting for nearly 20% of such prescriptions[1].
Pricing and Cost Considerations
The cost of Virtussin AC can vary, but generally, a 120 ml (4 oz) bottle of Virtussin AC syrup costs between $20-$25. This translates to about $5-$6.25 per day if taken at the maximum recommended dose of four doses a day. In contrast, Cheratussin AC, with a similar quantity, ranges between $10-$15, making it approximately $2.50-$3.75 per day at maximum dosage[1].
Generic and Branded Versions
Generic versions of guaifenesin/codeine phosphate syrups are typically less expensive than their branded counterparts. The cost of generics can vary based on location and insurance coverage but generally offers a more affordable option for patients[1].
Price Projections and Inflation
The pharmaceutical market is expected to see a moderate increase in drug prices. According to Vizient's Pharmacy Market Outlook, the overall drug price inflation rate is projected to be around 3.8% for 2024, driven in part by specialty pharmaceuticals, including those for chronic and complex conditions[2].
For medications like Virtussin AC, which are not classified as specialty drugs but are part of the broader pharmaceutical market, the price increase is likely to follow the general trend. This means that the cost of Virtussin AC could rise by a similar percentage, although the exact increase may vary based on factors such as manufacturer adjustments, market competition, and regulatory changes.
Impact of Market Trends
Several market trends could influence the pricing and availability of Virtussin AC:
Specialty Pharmaceuticals
The increasing use of high-cost specialty medications, such as those for weight loss and gene therapies, is driving up overall drug costs. However, this does not directly impact the pricing of Virtussin AC but indicates a broader trend of rising drug costs[2].
Biosimilars
The growth of biosimilars, which are lower-cost alternatives to branded biologic drugs, can moderate overall drug price increases. While Virtussin AC is not a biologic, the general trend of increased use of cost-effective alternatives can influence pricing strategies across the pharmaceutical sector[2][3].
Generic and Branded Drug Dynamics
The balance between branded and generic drug prices continues to play a crucial role in moderating overall drug cost increases. As generic versions of medications become more prevalent, they can reduce the average cost per prescription, which might indirectly affect the pricing of branded drugs like Virtussin AC[3].
Consumer and Prescriber Considerations
When choosing between Virtussin AC and other similar medications, several factors should be considered:
Efficacy and Side Effects
Both Virtussin AC and Cheratussin AC are effective in managing cough and congestion, but they differ in their side effect profiles and additional ingredients. Cheratussin AC includes pseudoephedrine, a nasal decongestant, which may be beneficial for patients with congestive symptoms[1].
Cost and Insurance Coverage
The cost difference between Virtussin AC and its generic or branded alternatives can be significant. Patients should consider their insurance coverage and out-of-pocket costs when selecting a medication[1].
Key Takeaways
- Market Presence: Virtussin AC is a widely prescribed medication for cough and congestion, with a significant market share.
- Pricing: The cost of Virtussin AC is generally higher than its counterpart Cheratussin AC but can vary based on generic options and insurance coverage.
- Price Projections: The pharmaceutical market is expected to see a moderate increase in drug prices, with Virtussin AC likely to follow this trend.
- Market Trends: The growth of specialty pharmaceuticals, biosimilars, and generic drugs influences the broader pharmaceutical market and can impact pricing strategies.
FAQs
1. What are the active ingredients in Virtussin AC? Virtussin AC contains codeine phosphate (10 mg per 5 mL) as an antitussive and guaifenesin (100 mg per 5 mL) as an expectorant[4].
2. How is Virtussin AC typically dosed? The typical dose is 5–10 mL every 4 to 6 hours, not to exceed 40 mL per day for adults and adolescents over 12 years old[1].
3. What conditions does Virtussin AC treat? Virtussin AC is used to relieve coughs and congestion associated with common colds, allergies, and respiratory illnesses like bronchitis[1][4].
4. How does Virtussin AC compare to Cheratussin AC in terms of cost? Cheratussin AC is generally less expensive than Virtussin AC, with a daily cost of approximately $2.50-$3.75 compared to $5-$6.25 for Virtussin AC[1].
5. What are the potential risks associated with Virtussin AC? Virtussin AC contains codeine, which carries a risk of addiction. Patients should be cautious and follow the prescribed dosage to minimize this risk[1].
Sources
- Virtussin Ac vs Cheratussin | Power - Clinical Trials
- Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals
- Vizient Projects 3.26% Drug Price Inflation Rate for 2023 in Latest Pharmacy Market Outlook
- Virtussin AC (liquid) Virtus Pharmaceuticals LLC - Drugs.com
More… ↓
